Laya Ekhlaspour

Laya Ekhlaspour

MD

Pediatric endocrinologist
Physician-scientist tackling type 1 diabetes with technology

Contact me

Contact me

About me

Pronouns: She | Her | Hers

Telehealth (video visits)
Insurance plan info

Dr. Laya Ekhlaspour is a pediatric endocrinologist who cares for children with conditions related to the body's hormones, including type 1 and type 2 diabetes. She has a special interest in using technology to help control blood sugar levels and make living with diabetes easier.

Ekhlaspour's research focuses on developing and testing new ways to manage diabetes, including continuous glucose monitors and automated insulin delivery systems, and on new insulin therapies. She received a grant from the National Institutes of Health to study how automating insulin administration could improve blood sugar control after meals.

Originally from Iran, Ekhlaspour earned her medical degree at Kerman University of Medical Sciences in Iran. She completed a residency in pediatrics at the Icahn School of Medicine at Mount Sinai, followed by a fellowship in pediatric endocrinology at Harvard Medical School and Massachusetts General Hospital.

Ekhlaspour is a member of the American Diabetes Association, Endocrine Society, Pediatric Endocrine Society and International Society of Pediatrics and Adolescents with Diabetes.

  • Board Certifications

    American Board of Pediatrics, Pediatric Endocrinology

    American Academy of Pediatrics, General Pediatrics

  • Fellowships

    Massachusetts General Hospital, Pediatric Endocrinology

  • Residencies

    Icahn School of Medicine at Mount Sinai, Pediatrics

  • Internship

    Icahn School of Medicine at Mount Sinai, Pediatrics

  • Degree

    MD, Kermanshah University of Medical Sciences and Health Services School of Medicine

My goal is to support families with diabetes by empowering them to use technologies that make managing the condition easier.

Where I see patients (2)

    Selected research

    See all research
    Decorative Caduceus

    Feasibility of CGM Use in Hospitalized Youth

    Glycemic data related to time in range, time hypoglycemic, time hyperglycemic and the time of first onset of hypoglycemia and hyperglycemia will be obtained by both CGM and point of care glucose values.

    Recruiting

    More about this study
    Decorative Caduceus

    AIDANET Pediatrics

    Non-inferiority of the mean CGM between the two weeks of the Usual Care observational period and the two weeks of AIDANET at-home

    Recruiting

    More about this study
    Decorative Caduceus

    Extended Bolus for Meals in a Closed-loop System

    Area under the curve between glucose trace and starting glucose (mg/dL* hour)

    Recruiting

    More about this study
    See all clinical trials

    Contact me

    Translation, please

    We have interpreters for Cantonese, Mandarin, Spanish, Russian, American Sign Language and more.

    Request an interpreter

    Share